Active Infection & Immunity Pregnancy, Children & Inherited Conditions

Cholera control in endemic regions of Africa: assessing mass preventative OCV campaigns impacts and strategies

In plain English

AI plain-English summary

Cholera vaccines are being given to entire populations in two cities in the Democratic Republic of Congo to find out how well they work and how often people need them. Cholera kills thousands of people each year in Africa, and the oral cholera vaccine (OCV) is recommended for prevention, but no one knows the best way to use it—how long protection lasts, whether children need different doses, or how population movement affects coverage. This project fills those gaps by tracking confirmed cases in Goma and Bukama, using a case-cohort design to calculate vaccine effectiveness by age and regimen, and running regular surveys on coverage, migration, and access to care. If the research succeeds, health authorities in cholera-endemic regions will have clear, evidence-based guidelines on revaccination timing and campaign design. That could shift cholera control from reactive outbreak response to sustained, cost-effective prevention—saving lives and reducing strain on fragile health systems without requiring dramatic new infrastructure. The collaboration with DRC authorities and Epicentre’s long-standing field presence means the results are likely to be implemented quickly where they matter most.

View original technical description
Cholera remains an important public health issue worldwide. Although OCV is recommended for use in cholera preventative control actions, much remains unknown on the vaccine performances and most appropriate vaccination strategies. This project proposes to answer some of these knowledge gaps by assessing the strategies and impact of preventative OCV mass campaigns in different cholera hotspots in the DRC. The specific objectives include advanced estimations of vaccine effectiveness, by age and under different vaccination regimen, reviewing re-vaccination delays, and assessing factors influencing strategies’ success such as population movements and access to care. It will be conducted in two sites in DRC (Goma and Bukama), where Epicentre has long been engaged in cholera research, and comprises several activities: continued surveillance and confirmation of suspect cholera cases; an innovative case-cohort design for vaccine effectiveness calculations; regular surveys in both sites (including vaccine coverage, population movements, mortality and access to care assessments); and qualitative assessments on care and vaccination perceptions. Our meaningful collaboration with DRC authorities and laboratories, deep knowledge of study sites, and strong field implementation setup will be strengths to implement this study with low risk and high probability of success.

View the original record at the funder ↗

Researchers

Anais BROBAN (EPMC Awardee)Daniel Mukadi (EPMC Awardee)Sophie Meakin (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Measuring Impact and Effectiveness of Cholera Vaccines in Uvira, Democratic Republic of the Congo
Optimizing the Use of Oral Cholera Vaccine for Enhanced Impact: A Randomized Controlled Trial and Observational Study to Inform Vaccination Strategies in Kenya
Real-world Effectiveness of Oral Cholera Vaccines in Preventing Cholera in Mozambique - REOP
Optimizing vaccine allocation for cholera epidemics
Evidence Based Targeted Water, Sanitation, and Hygiene Interventions to Reduce Cholera in Hotspots in the Democratic Republic of the Congo

Original classification

Directed Call

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.